cycloserine has been researched along with zolmitriptan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bourgoin, S; Hamon, M; Kayser, V; Latrémolière, A | 1 |
1 review(s) available for cycloserine and zolmitriptan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for cycloserine and zolmitriptan
| Article | Year |
|---|---|
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Cycloserine; Dihydroergotamine; Disease Models, Animal; Drug Synergism; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Motor Activity; Oxazolidinones; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sciatica; Serotonin 5-HT1 Receptor Agonists; Trigeminal Neuralgia; Tryptamines | 2011 |